CRICUT INC - CLASS A (CRCT) Fundamental Analysis & Valuation

NASDAQ:CRCT • US22658D1000

Current stock price

4.5 USD
+0.15 (+3.45%)
At close:
4.5 USD
0 (0%)
After Hours:

This CRCT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CRCT Profitability Analysis

1.1 Basic Checks

  • In the past year CRCT was profitable.
  • In the past year CRCT had a positive cash flow from operations.
  • Each year in the past 5 years CRCT has been profitable.
  • CRCT had a positive operating cash flow in 4 of the past 5 years.
CRCT Yearly Net Income VS EBIT VS OCF VS FCFCRCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • CRCT has a Return On Assets of 13.21%. This is amongst the best in the industry. CRCT outperforms 96.67% of its industry peers.
  • The Return On Equity of CRCT (22.33%) is better than 90.00% of its industry peers.
  • CRCT has a Return On Invested Capital of 19.04%. This is amongst the best in the industry. CRCT outperforms 96.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CRCT is above the industry average of 9.09%.
  • The last Return On Invested Capital (19.04%) for CRCT is above the 3 year average (13.50%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.21%
ROE 22.33%
ROIC 19.04%
ROA(3y)9.81%
ROA(5y)9.96%
ROE(3y)15.27%
ROE(5y)15.14%
ROIC(3y)13.5%
ROIC(5y)13.7%
CRCT Yearly ROA, ROE, ROICCRCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 10.82%, CRCT belongs to the top of the industry, outperforming 88.33% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CRCT has declined.
  • CRCT's Operating Margin of 13.63% is amongst the best of the industry. CRCT outperforms 83.33% of its industry peers.
  • In the last couple of years the Operating Margin of CRCT has declined.
  • Looking at the Gross Margin, with a value of 55.08%, CRCT belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CRCT has grown nicely.
Industry RankSector Rank
OM 13.63%
PM (TTM) 10.82%
GM 55.08%
OM growth 3Y13.38%
OM growth 5Y-8.2%
PM growth 3Y16.48%
PM growth 5Y-7.66%
GM growth 3Y11.74%
GM growth 5Y9.71%
CRCT Yearly Profit, Operating, Gross MarginsCRCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CRCT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CRCT is creating value.
  • Compared to 1 year ago, CRCT has less shares outstanding
  • CRCT has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for CRCT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRCT Yearly Shares OutstandingCRCT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CRCT Yearly Total Debt VS Total AssetsCRCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • CRCT has an Altman-Z score of 4.76. This indicates that CRCT is financially healthy and has little risk of bankruptcy at the moment.
  • CRCT has a better Altman-Z score (4.76) than 78.33% of its industry peers.
  • There is no outstanding debt for CRCT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.76
ROIC/WACC1.98
WACC9.64%
CRCT Yearly LT Debt VS Equity VS FCFCRCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • CRCT has a Current Ratio of 2.26. This indicates that CRCT is financially healthy and has no problem in meeting its short term obligations.
  • CRCT has a worse Current ratio (2.26) than 60.00% of its industry peers.
  • A Quick Ratio of 1.80 indicates that CRCT should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.80, CRCT is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 1.8
CRCT Yearly Current Assets VS Current LiabilitesCRCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CRCT Growth Analysis

3.1 Past

  • CRCT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.14%, which is quite impressive.
  • The earnings per share for CRCT have been decreasing by -12.80% on average. This is quite bad
  • CRCT shows a decrease in Revenue. In the last year, the revenue decreased by -0.53%.
  • Measured over the past years, CRCT shows a decrease in Revenue. The Revenue has been decreasing by -5.87% on average per year.
EPS 1Y (TTM)24.14%
EPS 3Y8.74%
EPS 5Y-12.8%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-0.53%
Revenue growth 3Y-7.18%
Revenue growth 5Y-5.87%
Sales Q2Q%-2.73%

3.2 Future

  • CRCT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -19.13% yearly.
  • The Revenue is expected to grow by 0.45% on average over the next years.
EPS Next Y-63.17%
EPS Next 2Y-33.37%
EPS Next 3Y-19.13%
EPS Next 5YN/A
Revenue Next Year-1.29%
Revenue Next 2Y-0.16%
Revenue Next 3Y0.45%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CRCT Yearly Revenue VS EstimatesCRCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
CRCT Yearly EPS VS EstimatesCRCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

5

4. CRCT Valuation Analysis

4.1 Price/Earnings Ratio

  • CRCT is valuated correctly with a Price/Earnings ratio of 12.50.
  • 65.00% of the companies in the same industry are more expensive than CRCT, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.87. CRCT is valued rather cheaply when compared to this.
  • CRCT is valuated quite expensively with a Price/Forward Earnings ratio of 33.94.
  • 71.67% of the companies in the same industry are cheaper than CRCT, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.51, CRCT is valued at the same level.
Industry RankSector Rank
PE 12.5
Fwd PE 33.94
CRCT Price Earnings VS Forward Price EarningsCRCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRCT indicates a rather cheap valuation: CRCT is cheaper than 90.00% of the companies listed in the same industry.
  • 91.67% of the companies in the same industry are more expensive than CRCT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.42
EV/EBITDA 5.43
CRCT Per share dataCRCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • CRCT has an outstanding profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as CRCT's earnings are expected to decrease with -19.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-33.37%
EPS Next 3Y-19.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. CRCT Dividend Analysis

5.1 Amount

  • CRCT has a Yearly Dividend Yield of 4.60%, which is a nice return.
  • CRCT's Dividend Yield is rather good when compared to the industry average which is at 1.32. CRCT pays more dividend than 90.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, CRCT pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.6%

5.2 History

  • CRCT has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
CRCT Yearly Dividends per shareCRCT Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 263.48% of the earnings are spent on dividend by CRCT. This is not a sustainable payout ratio.
DP263.48%
EPS Next 2Y-33.37%
EPS Next 3Y-19.13%
CRCT Yearly Income VS Free CF VS DividendCRCT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M
CRCT Dividend Payout.CRCT Dividend Payout, showing the Payout Ratio.CRCT Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CRCT Fundamentals: All Metrics, Ratios and Statistics

CRICUT INC - CLASS A

NASDAQ:CRCT (4/17/2026, 8:03:47 PM)

After market: 4.5 0 (0%)

4.5

+0.15 (+3.45%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)03-03
Earnings (Next)05-05
Inst Owners54.53%
Inst Owner Change0.05%
Ins Owners9.97%
Ins Owner Change24.63%
Market Cap953.01M
Revenue(TTM)708.78M
Net Income(TTM)76.70M
Analysts40
Price Target3.52 (-21.78%)
Short Float %11.58%
Short Ratio9.51
Dividend
Industry RankSector Rank
Dividend Yield 4.6%
Yearly Dividend0.95
Dividend Growth(5Y)N/A
DP263.48%
Div Incr Years1
Div Non Decr Years1
Ex-Date01-06
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)108.75%
Min EPS beat(2)47.04%
Max EPS beat(2)170.45%
EPS beat(4)4
Avg EPS beat(4)83.98%
Min EPS beat(4)47.04%
Max EPS beat(4)170.45%
EPS beat(8)7
Avg EPS beat(8)63.97%
EPS beat(12)9
Avg EPS beat(12)40.48%
EPS beat(16)9
Avg EPS beat(16)25.61%
Revenue beat(2)1
Avg Revenue beat(2)3.16%
Min Revenue beat(2)-0.04%
Max Revenue beat(2)6.35%
Revenue beat(4)3
Avg Revenue beat(4)3.58%
Min Revenue beat(4)-0.04%
Max Revenue beat(4)6.35%
Revenue beat(8)3
Avg Revenue beat(8)-0.27%
Revenue beat(12)3
Avg Revenue beat(12)-3.3%
Revenue beat(16)5
Avg Revenue beat(16)-3.4%
PT rev (1m)3.5%
PT rev (3m)-4.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-30.43%
EPS NY rev (1m)-22.16%
EPS NY rev (3m)-25.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.07%
Valuation
Industry RankSector Rank
PE 12.5
Fwd PE 33.94
P/S 1.34
P/FCF 5.42
P/OCF 4.76
P/B 2.77
P/tB 2.77
EV/EBITDA 5.43
EPS(TTM)0.36
EY8%
EPS(NY)0.13
Fwd EY2.95%
FCF(TTM)0.83
FCFY18.45%
OCF(TTM)0.95
OCFY21.01%
SpS3.35
BVpS1.62
TBVpS1.62
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.62495 (-19.45%)
Profitability
Industry RankSector Rank
ROA 13.21%
ROE 22.33%
ROCE 26.86%
ROIC 19.04%
ROICexc 81.48%
ROICexgc 81.48%
OM 13.63%
PM (TTM) 10.82%
GM 55.08%
FCFM 24.81%
ROA(3y)9.81%
ROA(5y)9.96%
ROE(3y)15.27%
ROE(5y)15.14%
ROIC(3y)13.5%
ROIC(5y)13.7%
ROICexc(3y)45.27%
ROICexc(5y)36.11%
ROICexgc(3y)45.27%
ROICexgc(5y)36.13%
ROCE(3y)19.04%
ROCE(5y)19.32%
ROICexgc growth 3Y76.34%
ROICexgc growth 5Y-8.75%
ROICexc growth 3Y76.45%
ROICexc growth 5Y-8.37%
OM growth 3Y13.38%
OM growth 5Y-8.2%
PM growth 3Y16.48%
PM growth 5Y-7.66%
GM growth 3Y11.74%
GM growth 5Y9.71%
F-Score8
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 99.91%
Cap/Sales 3.44%
Interest Coverage 250
Cash Conversion 165.38%
Profit Quality 229.21%
Current Ratio 2.26
Quick Ratio 1.8
Altman-Z 4.76
F-Score8
WACC9.64%
ROIC/WACC1.98
Cap/Depr(3y)80.69%
Cap/Depr(5y)110.36%
Cap/Sales(3y)3.04%
Cap/Sales(5y)3.13%
Profit Quality(3y)371.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.14%
EPS 3Y8.74%
EPS 5Y-12.8%
EPS Q2Q%-33.33%
EPS Next Y-63.17%
EPS Next 2Y-33.37%
EPS Next 3Y-19.13%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.53%
Revenue growth 3Y-7.18%
Revenue growth 5Y-5.87%
Sales Q2Q%-2.73%
Revenue Next Year-1.29%
Revenue Next 2Y-0.16%
Revenue Next 3Y0.45%
Revenue Next 5YN/A
EBIT growth 1Y26.14%
EBIT growth 3Y5.24%
EBIT growth 5Y-13.58%
EBIT Next Year-22.62%
EBIT Next 3Y0.58%
EBIT Next 5YN/A
FCF growth 1Y-28.71%
FCF growth 3Y27.97%
FCF growth 5Y-4.93%
OCF growth 1Y-24.43%
OCF growth 3Y19.38%
OCF growth 5Y-4.2%

CRICUT INC - CLASS A / CRCT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CRICUT INC - CLASS A (CRCT) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CRCT.


What is the valuation status for CRCT stock?

ChartMill assigns a valuation rating of 5 / 10 to CRICUT INC - CLASS A (CRCT). This can be considered as Fairly Valued.


How profitable is CRICUT INC - CLASS A (CRCT) stock?

CRICUT INC - CLASS A (CRCT) has a profitability rating of 8 / 10.


How financially healthy is CRICUT INC - CLASS A?

The financial health rating of CRICUT INC - CLASS A (CRCT) is 8 / 10.


What is the earnings growth outlook for CRICUT INC - CLASS A?

The Earnings per Share (EPS) of CRICUT INC - CLASS A (CRCT) is expected to decline by -63.17% in the next year.